On September 16, 2024, Stanford University and Elsevier jointly released the list of the world’s top 2% scientists. This list primarily focuses on two rankings: the “Career-long Impact,” which highlights lifetime scientific influence, and the “Single-year Impact,” which emphasizes academic achievements within a single year. We are excited to congratulate forty-eight Editorial Board members from the Cancer Drug Resistance (CDR) journal who were included in the “World’s Top 2% Scientists” list. Among them, 27 Editorial Board members were featured on both the “Career-long Impact” and "Single-year Impact" lists, 4 Editorial Board members were included in the “Career-long Impact” ranking, 17 Editorial Board members were featured in the “Single-year Impact” ranking, which focuses on annual academic achievements. The lists are as follows: